Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
EyeGate Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
EyeGate Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
EyeGate Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
EyeGate Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
EyeGate Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 11
EyeGate Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
EyeGate Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
EyeGate Pharma Raises USD2.6 Million in Venture Financing 13
EyeGate Pharma Raises USD1 Million in Venture Financing 14
Jade Therapeutics To Raise US$0.6 Million In Venture Financing 15
EyeGate Pharma Raises US$1 Million In Venture Financing 16
EyeGate Pharma Secures An Additional US$5.9 Million In Series D Round Of Financing 17
Partnerships 18
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 18
Licensing Agreements 20
EyeGate Pharma Enters into Licensing Agreement with University Of Utah Research Foundation 20
BioTime Extends Licensing Agreement With Jade Therapeutics For HyStem Technology 21
BioTime Enters Into Licensing Agreement With Jade Therapeutics For HyStem 22
Equity Offering 23
EyeGate Pharma Raises USD10 Million in Public Offering of Shares and Warrants 23
EyeGate Pharma Raises USD3.8 Million in Private Placement of Shares and Preferred Stock 24
EyeGate Pharma Raises USD10 Million in Public Offering of Shares 26
EyeGate Pharma Raises USD4.1 Million in IPO 28
Acquisition 30
Eyegate Pharma Acquires Jade Therapeutics 30
EyeGate Pharmaceuticals Inc – Key Competitors 31
EyeGate Pharmaceuticals Inc – Key Employees 32
EyeGate Pharmaceuticals Inc – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Financial Announcements 34
Nov 14, 2017: EyeGate Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update 34
Aug 07, 2017: EyeGate Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update 36
May 08, 2017: EyeGate Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update 37
Feb 23, 2017: EyeGate Pharmaceuticals Reports Full-year 2016 Financial Results and Provides Business Update 39
Nov 02, 2016: EyeGate Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update 40
Aug 10, 2016: EyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update 41
May 13, 2016: Eyegate Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business Update 43
Mar 29, 2016: EyeGate Reports Full-year 2015 Financial Results and Provides Business Update 45
Corporate Communications 46
Nov 01, 2017: EyeGate Appoints Mike Garanzini as Chief Commercial Officer to Develop and Implement Global Launch Strategy 46
Oct 23, 2017: Eye Care Thought Leaders Join EyeGate Scientific Advisory Board 47
Feb 06, 2017: EyeGate Pharmaceuticals Announces Executive Promotions 48
Apr 27, 2016: EyeGate Pharma Appoints Ryan R. Brenneman as Chief Financial Officer 49
Government and Public Interest 50
Sep 13, 2016: EyeGate Awarded $448,185 for second year of funding of Phase II SBIR Grant from U.S. Department of Defense 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51
EyeGate Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
EyeGate Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
EyeGate Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
EyeGate Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
EyeGate Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 9
EyeGate Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 11
EyeGate Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
EyeGate Pharma Raises USD2.6 Million in Venture Financing 13
EyeGate Pharma Raises USD1 Million in Venture Financing 14
Jade Therapeutics To Raise US$0.6 Million In Venture Financing 15
EyeGate Pharma Raises US$1 Million In Venture Financing 16
EyeGate Pharma Secures An Additional US$5.9 Million In Series D Round Of Financing 17
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 18
EyeGate Pharma Enters into Licensing Agreement with University Of Utah Research Foundation 20
BioTime Extends Licensing Agreement With Jade Therapeutics For HyStem Technology 21
BioTime Enters Into Licensing Agreement With Jade Therapeutics For HyStem 22
EyeGate Pharma Raises USD10 Million in Public Offering of Shares and Warrants 23
EyeGate Pharma Raises USD3.8 Million in Private Placement of Shares and Preferred Stock 24
EyeGate Pharma Raises USD10 Million in Public Offering of Shares 26
EyeGate Pharma Raises USD4.1 Million in IPO 28
Eyegate Pharma Acquires Jade Therapeutics 30
EyeGate Pharmaceuticals Inc, Key Competitors 31
EyeGate Pharmaceuticals Inc, Key Employees 32
EyeGate Pharmaceuticals Inc, Subsidiaries 33